- Home
- ACIU vs PMF Comparison
ACIU vs PMF Comparison
Compare ACIU & PMF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- PMF
- Stock Information
- Founded
- ACIU 2003
- PMF 2001
- Country
- ACIU Switzerland
- PMF United States
- Employees
- ACIU N/A
- PMF N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- PMF Finance/Investors Services
- Sector
- ACIU Health Care
- PMF Finance
- Exchange
- ACIU Nasdaq
- PMF Nasdaq
- Market Cap
- ACIU 173.7M
- PMF 207.9M
- IPO Year
- ACIU 2016
- PMF N/A
- Fundamental
- Price
- ACIU $1.68
- PMF $8.24
- Analyst Decision
- ACIU Strong Buy
- PMF
- Analyst Count
- ACIU 2
- PMF 0
- Target Price
- ACIU $10.00
- PMF N/A
- AVG Volume (30 Days)
- ACIU 137.1K
- PMF 61.3K
- Earning Date
- ACIU 04-30-2025
- PMF 01-01-0001
- Dividend Yield
- ACIU N/A
- PMF 5.36%
- EPS Growth
- ACIU N/A
- PMF N/A
- EPS
- ACIU N/A
- PMF N/A
- Revenue
- ACIU $32,014,254.00
- PMF N/A
- Revenue This Year
- ACIU N/A
- PMF N/A
- Revenue Next Year
- ACIU $676.94
- PMF N/A
- P/E Ratio
- ACIU N/A
- PMF N/A
- Revenue Growth
- ACIU 91.20
- PMF N/A
- 52 Week Low
- ACIU $1.43
- PMF $7.69
- 52 Week High
- ACIU $4.98
- PMF $10.56
- Technical
- Relative Strength Index (RSI)
- ACIU 46.75
- PMF 49.23
- Support Level
- ACIU $1.55
- PMF $8.17
- Resistance Level
- ACIU $1.79
- PMF $8.34
- Average True Range (ATR)
- ACIU 0.10
- PMF 0.11
- MACD
- ACIU 0.03
- PMF 0.06
- Stochastic Oscillator
- ACIU 66.67
- PMF 81.48
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About PMF PIMCO Municipal Income Fund
PIMCO Municipal Income Fund is a closed-end management investment company. Its primary investment objective is to seek to provide current income exempt from federal income tax. The fund invests a majority of its net assets in municipal bonds that pay interest that is exempt from federal income tax.